Does TOFACITINIB Cause Muscular weakness? 1,583 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,583 reports of Muscular weakness have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.0% of all adverse event reports for TOFACITINIB.
1,583
Reports of Muscular weakness with TOFACITINIB
1.0%
of all TOFACITINIB reports
652
Deaths
825
Hospitalizations
How Dangerous Is Muscular weakness From TOFACITINIB?
Of the 1,583 reports, 652 (41.2%) resulted in death, 825 (52.1%) required hospitalization, and 661 (41.8%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,583 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which TOFACITINIB Alternatives Have Lower Muscular weakness Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN